Fabrizio Cantini
Prato, 59100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers.
Journal: Journal of personalized medicine
Published: September 18, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65).
Journal: Journal of personalized medicine
Published: May 03, 2024
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.
Journal: Frontiers in medicine
Published: October 25, 2023
Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases.
Journal: Frontiers in medicine
Published: August 02, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice.
Journal: Journal of personalized medicine
Published: August 01, 2023
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials.
Journal: Rheumatology (Oxford, England)
Published: July 04, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.
Journal: Biomedicines
Published: January 21, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
Journal: Annals of the rheumatic diseases
Published: January 14, 2023
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 12, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.
Journal: Clinical and experimental rheumatology
Published: April 13, 2022
Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements.
Journal: Expert opinion on drug safety
Published: December 23, 2021
Last Updated: 09/26/2026